A new nano-vaccine for brain tumors
Novel nano-vaccine technology for inducing immunity against gliomas
This research is developing a new type of nano-vaccine to help the body's immune system fight against a specific kind of adult brain tumor called glioma.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11168969 on NIH RePORTER |
What this research studies
We are working on a new vaccine approach to help patients with gliomas, a type of brain tumor. Current immune therapies don't always work well for these tumors, so we need better options. Our goal is to create a powerful and safe vaccine using tiny particles called synthetic high-density lipoprotein (sHDL) nanodiscs. These nanodiscs are designed to deliver specific tumor markers and immune-boosting molecules to the body's immune cells, teaching them to recognize and attack the glioma cells, especially those with a common mutation called mIDH1.
Who could benefit from this research
Good fit: This research is most relevant for adult patients with gliomas, particularly those whose tumors have the mIDH1 mutation.
Not a fit: Patients whose gliomas do not have the mIDH1 mutation or those with other types of brain tumors may not directly benefit from this specific vaccine approach.
Why it matters
Potential benefit: If successful, this nano-vaccine could offer a new way to create strong and lasting immune responses against gliomas, potentially improving treatment outcomes for patients.
How similar studies have performed: While immune therapies have shown success in some cancers, this specific nano-vaccine technology for mIDH1 gliomas is a novel and untested approach.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Moon, James J. — University of Michigan at Ann Arbor
- Study coordinator: Moon, James J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.